A novel tris(chelate) metalloligand has been used to synthesize a chiral, heterometallic metal-organic framework that is robust to solvent removal and shows selective uptake of nitroaromatic compounds.
No takes yet. Share an insight, caveat, or question.
Murphy et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: